المؤلفون: Polley MC; Department of Public Health Sciences, University of Chicago, Chicago, Illinois, USA.; NRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania, USA., Schwartz D; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Karrison T; Department of Public Health Sciences, University of Chicago, Chicago, Illinois, USA.; NRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania, USA., Dignam JJ; Department of Public Health Sciences, University of Chicago, Chicago, Illinois, USA.; NRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania, USA.

المصدر: Neuro-oncology [Neuro Oncol] 2024 May 03; Vol. 26 (5), pp. 796-810.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Review

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Research Design*/standards , Brain Neoplasms*/therapy , Glioblastoma*/therapy, Humans ; Clinical Trials as Topic/standards ; Randomized Controlled Trials as Topic/methods

المؤلفون: Chen WC; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA. william.chen@ucsf.edu.; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA. william.chen@ucsf.edu.; Department of Pathology, University of California San Francisco, San Francisco, CA, USA. william.chen@ucsf.edu., Choudhury A; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.; Department of Pathology, University of California San Francisco, San Francisco, CA, USA.; Medical Scientist Training Program, University of California San Francisco, San Francisco, CA, USA., Youngblood MW; Department of Neurological Surgery, Northwestern University, Chicago, IL, USA., Polley MC; NRG Statistics and Data Management Center, NRG Oncology, Philadelphia, PA, USA., Lucas CG; Department of Pathology, Johns Hopkins University, Baltimore, MD, USA., Mirchia K; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.; Department of Pathology, University of California San Francisco, San Francisco, CA, USA., Maas SLN; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., Suwala AK; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.; Department of Neuropathology, University Hospital Heidelberg and CCU Neuropathology, German Consortium for Translational Cancer Research, German Cancer Research Center, Heidelberg, Germany., Won M; NRG Statistics and Data Management Center, NRG Oncology, Philadelphia, PA, USA., Bayley JC; Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX, USA., Harmanci AS; Department of Neurosurgery, Baylor College of Medicine, Houston, TX, USA., Harmanci AO; Center for Secure Artificial Intelligence for Healthcare, Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center, Houston, TX, USA., Klisch TJ; Department of Molecular and Human Genetics, Baylor College of Medicine, and Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX, USA., Nguyen MP; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.; Department of Pathology, University of California San Francisco, San Francisco, CA, USA., Vasudevan HN; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA., McCortney K; Department of Neurological Surgery, Northwestern University, Chicago, IL, USA., Yu TJ; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA., Bhave V; Department of Neurosurgery, Brigham and Women's Hospital, and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Lam TC; Department of Clinical Oncology, The University of Hong Kong, Pokfulam, China., Pu JK; Division of Neurosurgery, Department of Surgery, The University of Hong Kong, Pokfulam, China., Li LF; Division of Neurosurgery, Department of Surgery, The University of Hong Kong, Pokfulam, China., Leung GK; Division of Neurosurgery, Department of Surgery, The University of Hong Kong, Pokfulam, China., Chan JW; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA., Perlow HK; Department of Radiation Oncology, Ohio State University, Columbus, OH, USA., Palmer JD; Department of Radiation Oncology, Ohio State University, Columbus, OH, USA., Haberler C; Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria., Berghoff AS; Division of Oncology, Department of Medicine, Medical University of Vienna, Vienna, Austria., Preusser M; Division of Oncology, Department of Medicine, Medical University of Vienna, Vienna, Austria., Nicolaides TP; Caris Life Sciences, Phoenix, AZ, USA., Mawrin C; Department of Neuropathology, University of Magdeburg, Magdeburg, Germany., Agnihotri S; Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, USA., Resnick A; Department of Neurological Surgery, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Rood BR; Brain Tumor Institute, Children's National Hospital, Washington, DC, USA., Chew J; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA., Young JS; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.; Department of Pathology, University of California San Francisco, San Francisco, CA, USA., Boreta L; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA., Braunstein SE; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA., Schulte J; Neurosciences Department, University of California San Diego, La Jolla, CA, USA., Butowski N; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.; Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Santagata S; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Spetzler D; Caris Life Sciences, Phoenix, AZ, USA., Bush NAO; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA., Villanueva-Meyer JE; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA., Chandler JP; Department of Neurological Surgery, Northwestern University, Chicago, IL, USA., Solomon DA; Department of Pathology, University of California San Francisco, San Francisco, CA, USA., Rogers CL; NRG Statistics and Data Management Center, NRG Oncology, Philadelphia, PA, USA., Pugh SL; NRG Statistics and Data Management Center, NRG Oncology, Philadelphia, PA, USA., Mehta MP; NRG Statistics and Data Management Center, NRG Oncology, Philadelphia, PA, USA.; Miami Neuroscience Institute, Baptist Health, Miami, FL, USA., Sneed PK; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA., Berger MS; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA., Horbinski CM; Department of Neurological Surgery, Northwestern University, Chicago, IL, USA.; Department of Pathology, Northwestern University, Chicago, IL, USA., McDermott MW; Miami Neuroscience Institute, Baptist Health, Miami, FL, USA., Perry A; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.; Department of Pathology, University of California San Francisco, San Francisco, CA, USA., Bi WL; Department of Neurosurgery, Brigham and Women's Hospital, and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Patel AJ; Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX, USA., Sahm F; Department of Neuropathology, University Hospital Heidelberg and CCU Neuropathology, German Consortium for Translational Cancer Research, German Cancer Research Center, Heidelberg, Germany., Magill ST; Department of Neurological Surgery, Northwestern University, Chicago, IL, USA. stephen.magill@northwestern.edu., Raleigh DR; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA. david.raleigh@ucsf.edu.; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA. david.raleigh@ucsf.edu.; Department of Pathology, University of California San Francisco, San Francisco, CA, USA. david.raleigh@ucsf.edu.

المصدر: Nature medicine [Nat Med] 2023 Dec; Vol. 29 (12), pp. 3067-3076. Date of Electronic Publication: 2023 Nov 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: Meningeal Neoplasms*/genetics , Meningeal Neoplasms*/radiotherapy , Meningeal Neoplasms*/pathology , Meningioma*/genetics , Meningioma*/radiotherapy , Meningioma*/pathology, Humans ; Biomarkers ; Gene Expression Profiling ; Neoplasm Recurrence, Local/pathology ; Prospective Studies

المؤلفون: Porter AB; Mayo Clinic and Mayo Clinic Alix School of Medicine, Phoenix, AZ., Wen PY; Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, MA., Polley MC; University of Chicago Biological Sciences, Department of Public Health Sciences, Chicago, IL.

المصدر: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting [Am Soc Clin Oncol Educ Book] 2023 May; Vol. 43, pp. e389322.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101233985 Publication Model: Print Cited Medium: Internet ISSN: 1548-8756 (Electronic) Linking ISSN: 15488748 NLM ISO Abbreviation: Am Soc Clin Oncol Educ Book Subsets: MEDLINE

مواضيع طبية MeSH: Glioma*/diagnosis , Glioma*/genetics , Glioma*/therapy, Humans ; Precision Medicine/methods ; Internal Medicine

المؤلفون: Rahman R; Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: rrahman@bwh.harvard.edu., Polley MC; Department of Public Health Sciences, University of Chicago, Chicago, IL, USA., Alder L; Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA., Brastianos PK; Massachusetts General Hospital, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Anders CK; Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA., Tawbi HA; MD Anderson Cancer Center, Houston, TX, USA., Mehta M; Miami Cancer Institute, Baptist Hospital, Miami, FL, USA., Wen PY; Centre for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Geyer S; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., de Groot J; University of California San Francisco Brain Tumor Center, San Francisco, CA, USA., Zadeh G; Department of Neurological Surgery University of Toronto, Toronto, ON, Canada., Piantadosi S; Department of Surgery, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Galanis E; Department of Oncology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA., Khasraw M; Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA.

المصدر: The Lancet. Oncology [Lancet Oncol] 2023 Apr; Vol. 24 (4), pp. e161-e171.

نوع المنشور: Journal Article; Review; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/drug therapy, Humans ; Reproducibility of Results ; Medical Oncology ; Societies, Medical ; Drug Development

المؤلفون: Polley MC; Mei-Yin C. Polley, PhD, NRG Oncology Statistics and Data Management Center, Philadelphia, PA; Thierry Gorlia, PhD, EORTC, Brussels, Belgium; Andy B. Lassman, MD, Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, NewYork-Presbyterian Hospital, New York, NY; and Martin J. van den Bent, MD, Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Gorlia T; Mei-Yin C. Polley, PhD, NRG Oncology Statistics and Data Management Center, Philadelphia, PA; Thierry Gorlia, PhD, EORTC, Brussels, Belgium; Andy B. Lassman, MD, Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, NewYork-Presbyterian Hospital, New York, NY; and Martin J. van den Bent, MD, Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Lassman AB; Mei-Yin C. Polley, PhD, NRG Oncology Statistics and Data Management Center, Philadelphia, PA; Thierry Gorlia, PhD, EORTC, Brussels, Belgium; Andy B. Lassman, MD, Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, NewYork-Presbyterian Hospital, New York, NY; and Martin J. van den Bent, MD, Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., van den Bent MJ; Mei-Yin C. Polley, PhD, NRG Oncology Statistics and Data Management Center, Philadelphia, PA; Thierry Gorlia, PhD, EORTC, Brussels, Belgium; Andy B. Lassman, MD, Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, NewYork-Presbyterian Hospital, New York, NY; and Martin J. van den Bent, MD, Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Feb 01; Vol. 41 (4), pp. 934-935. Date of Electronic Publication: 2022 Oct 03.

نوع المنشور: Letter; Comment

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Lassman AB; Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY.; Herbert Irving Comprehensive Cancer Center, New York, NY.; NewYork-Presbyterian Hospital, New York, NY., Hoang-Xuan K; AP-HP, Sorbonne Université, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2, Paris, France., Polley MC; NRG Oncology Statistics and Data Management Center, Philadelphia, PA., Brandes AA; Department of Medical Oncology, AUSL/IRCCS Institute of Neurological Sciences, Bologna, Italy., Cairncross JG; Charbonneau Cancer Institute, University of Calgary, Calgary, Canada., Kros JM; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands., Ashby LS; Barrow Neurological Institute, Phoenix, AZ., Taphoorn MJB; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.; Department of Neurology, Haaglanden Medical Center, the Hague, the Netherlands., Souhami L; Department of Radiation Oncology, McGill University, Montreal, Quebec, Canada., Dinjens WNM; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands., Laack NN; Mayo Clinic Accruals for Rochester Methodist Hospital, Rochester, MN., Kouwenhoven MCM; Department of Neurology, Amsterdam Universities Medical Centers, location VUmc, Amsterdam, the Netherlands., Fink KL; Baylor University Medical Center, Houston, TX., French PJ; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Macdonald DR; London Regional Cancer Program, Western University, London, Canada (RT)., Lacombe D; EORTC, Brussels, Belgium., Won M; NRG Oncology Statistics and Data Management Center, Philadelphia, PA., Gorlia T; EORTC, Brussels, Belgium., Mehta MP; Miami Cancer Institute, Miami, FL., van den Bent MJ; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Aug 10; Vol. 40 (23), pp. 2539-2545. Date of Electronic Publication: 2022 Jun 22.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Brain Neoplasms*/drug therapy , Oligodendroglioma*/drug therapy, Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Clinical Trials, Phase III as Topic ; Humans ; Lomustine/therapeutic use ; Neoplasm Recurrence, Local/drug therapy ; Procarbazine/therapeutic use ; Vincristine/therapeutic use

المؤلفون: Shepherd JH; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC., Ballman K; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN., Polley MC; Department of Public Health Sciences, University of Chicago, Chicago, IL., Campbell JD; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN., Fan C; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC., Selitsky S; QuantBio LLC, Durham, NC., Fernandez-Martinez A; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC., Parker JS; Life Edit Therapeutics, RTP, NC., Hoadley KA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.; Department of Genetics, University of North Carolina, Chapel Hill, NC., Hu Z; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC., Li Y; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC., Soloway MG; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC., Spears PA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC., Singh B; White Plains Hospital, White Plains, NY., Tolaney SM; Dana-Farber/Partners CancerCare, Boston, MA., Somlo G; City of Hope Comprehensive Cancer Center, Duarte, CA., Port ER; Mount Sinai Medical Center, New York, NY., Ma C; Washington University School of Medicine, St Louis, MO., Kuzma C; FirstHealth Sanford Hematology and Oncology, Sanford, NC., Mamounas E; UF Health Cancer Center Orlando, Orlando, FL., Golshan M; Yale Cancer Center, Yale School of Medicine, New Haven, CT., Bellon JR; Dana-Farber/Partners CancerCare, Boston, MA., Collyar D; Patient Advocates In Research, Danville, CA., Hahn OM; University of Chicago Medical Center, Chicago, IL., Hudis CA; Memorial Sloan Kettering Cancer Center, New York, NY., Winer EP; Dana-Farber/Partners CancerCare, Boston, MA., Partridge A; Dana-Farber/Partners CancerCare, Boston, MA., Hyslop T; Department of Biostatistics & Bioinformatics, School of Medicine, Duke University, Durham, NC., Carey LA; Division of Hematology-Oncology, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC., Perou CM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.; Department of Genetics, University of North Carolina, Chapel Hill, NC., Sikov WM; Program in Women's Oncology, Women and Infants Hospital of Rhode Island and Warren Alpert Medical School of Brown University, Providence, RI.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Apr 20; Vol. 40 (12), pp. 1323-1334. Date of Electronic Publication: 2022 Jan 19.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/genetics , Triple Negative Breast Neoplasms*/drug therapy , Triple Negative Breast Neoplasms*/genetics , Triple Negative Breast Neoplasms*/pathology, Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Bevacizumab/therapeutic use ; Carboplatin/therapeutic use ; Female ; Humans ; Neoadjuvant Therapy/methods ; Neoplasm, Residual/drug therapy ; Paclitaxel/therapeutic use

المؤلفون: Polley MC; Affiliations of authors: Department of Public Health Sciences, The University of Chicago, Chicago, IL, USA.

المصدر: Journal of the National Cancer Institute [J Natl Cancer Inst] 2022 Mar 08; Vol. 114 (3), pp. 345-346.

نوع المنشور: Editorial; Research Support, N.I.H., Extramural; Comment

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/genetics, Biomarkers, Tumor/genetics ; Female ; Humans ; Receptor, ErbB-2 ; Risk Assessment

المؤلفون: Dai B; Department of Biostatistics, University of Iowa, Iowa City, USA., Polley MC; Department of Public Health Sciences, University of Chicago, 5841 S. Maryland Ave, Chicago, Illinois, USA.

المصدر: Statistics in biopharmaceutical research [Stat Biopharm Res] 2022; Vol. 14 (2), pp. 217-226. Date of Electronic Publication: 2020 Nov 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Statistical Association Country of Publication: United States NLM ID: 101507745 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1946-6315 (Print) Linking ISSN: 19466315 NLM ISO Abbreviation: Stat Biopharm Res Subsets: PubMed not MEDLINE

المؤلفون: Carter JM; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. carter.jodi@mayo.edu., Polley MC; Department of Public Health Sciences, The University of Chicago, Chicago, Illinois., Leon-Ferre RA; Department of Oncology, Mayo Clinic, Rochester, Minnesota., Sinnwell J; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota., Thompson KJ; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota., Wang X; Department of Health Sciences Research, Mayo Clinic, Jacksonville, Florida., Ma Y; Department of Health Sciences Research, Mayo Clinic, Jacksonville, Florida., Zahrieh D; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota., Kachergus JM; Department of Cancer Biology, Mayo Clinic, Jacksonville, Florida., Solanki M; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Boughey JC; Department of Surgery, Mayo Clinic, Rochester, Minnesota., Liu MC; Department of Oncology, Mayo Clinic, Rochester, Minnesota., Ingle JN; Department of Oncology, Mayo Clinic, Rochester, Minnesota., Kalari KR; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota., Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota., Thompson EA; Department of Cancer Biology, Mayo Clinic, Jacksonville, Florida., Goetz MP; Department of Oncology, Mayo Clinic, Rochester, Minnesota.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Oct 15; Vol. 27 (20), pp. 5628-5637. Date of Electronic Publication: 2021 Jun 09.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Triple Negative Breast Neoplasms/*immunology , Triple Negative Breast Neoplasms/*pathology , Tumor Microenvironment/*immunology, B7-H1 Antigen/analysis ; Female ; Humans ; Middle Aged ; Neoplasm Staging ; Triple Negative Breast Neoplasms/chemistry